{"id":"https://openalex.org/W3031574443","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9577","title":"Clinicopathologic characteristics and immunotherapy outcomes in SMARCA4-mutant (mut) non-small cell lung cancer (NSCLC).","display_name":"Clinicopathologic characteristics and immunotherapy outcomes in SMARCA4-mutant (mut) non-small cell lung cancer (NSCLC).","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3031574443","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9577","mag":"3031574443"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.9577","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9577","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.9577","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Joao Victor Machado Alessi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joao Victor Machado Alessi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057490235","display_name":"Carolyn Glass","orcid":"https://orcid.org/0000-0002-8850-9906","observed_orcids":["https://orcid.org/0000-0002-8850-9906"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn Glass","raw_affiliation_strings":["Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030450694","display_name":"Biagio Ricciuti","orcid":"https://orcid.org/0000-0002-0651-2678","observed_orcids":["https://orcid.org/0000-0002-0651-2678"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Biagio Ricciuti","raw_affiliation_strings":["Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052689241","display_name":"Liam Flinn Spurr","orcid":"https://orcid.org/0000-0001-6465-7739","observed_orcids":["https://orcid.org/0000-0001-6465-7739"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liam F. Spurr","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090956629","display_name":"Lynette Marie Sholl","orcid":"https://orcid.org/0000-0002-9532-9735","observed_orcids":["https://orcid.org/0000-0002-9532-9735"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynette M. Sholl","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086249998","display_name":"Mark Magdi Awad","orcid":"https://orcid.org/0000-0003-0928-5244","observed_orcids":["https://orcid.org/0000-0003-0928-5244"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark M. Awad","raw_affiliation_strings":["Massachusetts General Hospital, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Cambridge, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"9577","last_page":"9577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6255000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6255000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.2939000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.04910000041127205,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smarca4-mutation","display_name":"SMARCA4 mutation","score":0.9589999914169312},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/swi-snf-chromatin-remodeling","display_name":"SWI/SNF chromatin remodeling","score":0.8709999918937683},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.718999981880188},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.8190000057220459},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8769999742507935},{"id":"https://openalex.org/keywords/clinicopathological-features","display_name":"clinicopathological features","score":0.8330000042915344},{"id":"https://openalex.org/keywords/non-squamous-non-small-cell-lung-cancer","display_name":"non-squamous non-small cell lung cancer","score":0.7829999923706055},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.33500000834465027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9369999766349792},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6159999966621399},{"id":"https://openalex.org/keywords/driver-mutations","display_name":"driver mutations","score":0.4429999887943268},{"id":"https://openalex.org/keywords/smoking-history","display_name":"smoking history","score":0.3659999966621399},{"id":"https://openalex.org/keywords/sex-differences-in-treatment-response","display_name":"sex differences in treatment response","score":0.4490000009536743},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C80828422","wikidata":"https://www.wikidata.org/wiki/Q18031595","display_name":"SMARCA4","level":5,"score":0.9005916118621826},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7854598760604858},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5665169954299927},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5205803513526917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5172089338302612},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5075005888938904},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4894760847091675},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.47340402007102966},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4355366826057434},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3697872459888458},{"id":"https://openalex.org/C167227067","wikidata":"https://www.wikidata.org/wiki/Q5113739","display_name":"Chromatin remodeling","level":4,"score":0.2933799922466278},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1442088782787323},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14363157749176025},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.1332099437713623},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.10094645619392395},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0639156699180603}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.9577","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9577","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.9577","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8600000143051147,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388045456","https://openalex.org/W3136331407","https://openalex.org/W3030972949","https://openalex.org/W3027936046","https://openalex.org/W4283712951","https://openalex.org/W4229832877","https://openalex.org/W4306404900","https://openalex.org/W3111812619","https://openalex.org/W4248366929","https://openalex.org/W2954478868"],"abstract_inverted_index":{"9577":[0],"Background:":[1],"The":[2,306],"catalytic":[3],"unit":[4],"of":[5,22,127,143,160,170,204,309,334],"the":[6,14,28,62,202],"SWI/SNF":[7],"chromatin":[8],"remodeling":[9],"complex":[10],"is":[11,18],"encoded":[12],"by":[13,59,84],"SMARCA4":[15,66,112,119,122,199,259,310,328],"gene,":[16],"which":[17],"mutated":[19],"in":[20,37,125,178,210,247,315,346],"~10%":[21],"NSCLCs.":[23,182],"We":[24,41,133],"sought":[25],"to":[26,33,81,91,344],"characterize":[27],"clinicopathologic":[29,43,338],"characteristics":[30,115],"and":[31,44,69,87,121,130,166,289,340],"outcomes":[32,90,314,343],"immune":[34,92,191],"checkpoint":[35,93,192],"inhibition":[36,94],"SMARCA4-mutant":[38,96],"NSCLC.":[39,349],"Methods:":[40],"collected":[42],"genomic":[45,332],"data":[46],"from":[47],"patients":[48,104,185],"with":[49,105,186,336],"NSCLC":[50,188,318,335],"that":[51],"had":[52],"undergone":[53],"targeted":[54],"next":[55],"generation":[56],"sequencing":[57],"(NGS)":[58],"OncoPanel":[60],"at":[61],"Dana-Farber":[63],"Cancer":[64],"Institute.":[65],"frameshift,":[67],"nonsense,":[68],"splice-site":[70],"mutations":[71,78,174,329],"were":[72,76,98,116],"considered":[73],"pathogenic,":[74],"as":[75],"missense":[77],"if":[79],"predicted":[80],"be":[82],"pathogenic":[83],"Mutation":[85],"Assessor":[86],"Polyphen-2.":[88],"Clinical":[89],"among":[95,254],"NSCLCs":[97],"retrospectively":[99],"assessed.":[100],"Results:":[101],"Of":[102],"2690":[103],"NSCLC,":[106,251,256],"8%":[107],"(N":[108,195],"=":[109,139,196,219,232,245,270],"211)":[110],"harbored":[111,198],"mutations.":[113,200],"Clinicopathological":[114],"balanced":[117],"between":[118],"mut":[120,260,311,317,348],"wild-type":[123],"(wt)":[124],"terms":[126],"age,":[128],"histology,":[129],"PD-L1":[131],"expression.":[132],"observed":[134,207],"a":[135,148,157,167,257,262,272,290,331],"male":[136],"predominance":[137],"(P":[138,145,154,163,175],"0.03),":[140],"greater":[141],"use":[142],"tobacco":[144],"<":[146,155,164,176,287,304],"0.001),":[147,156,165,288],"higher":[149,158],"tumor":[150],"mutational":[151],"burden":[152],"(TMB)":[153],"prevalence":[159,169],"advanced":[161],"disease":[162],"lower":[168,264],"concurrent":[171,258,324],"targetable":[172],"driver":[173],"0.001)":[177],"SMARCA4mut":[179,250],"vs":[180,216,228,241,249,267,278,296],"SMARCA4wt":[181,248],"Among":[183],"513":[184],"nonsquamous":[187],"who":[189],"received":[190],"inhibitors,":[193],"11%":[194],"57)":[197],"From":[201],"start":[203],"immunotherapy,":[205],"we":[206],"no":[208],"difference":[209],"overall":[211,236],"response":[212],"rate":[213],"(ORR":[214],"21.5%":[215],"19.3%;":[217],"P":[218,231,244,269,286,303],"0.3),":[220],"median":[221,235],"progression":[222],"free":[223],"survival":[224,237],"(mPFS":[225],"3.2":[226],"months":[227,240,277,295],"2.1":[229],"months;":[230,243,298],"0.4),":[233],"or":[234],"(mOS":[238],"12.0":[239],"8.2":[242],"0.09)":[246],"respectively.":[252],"However,":[253],"KRASmut":[255],"conferred":[261],"significantly":[263,273,291],"ORR":[265],"(23.1%":[266],"0.0%;":[268],"0.02),":[271],"shorter":[274,292],"mPFS":[275],"(4.8":[276],"1.7":[279],"month;":[280],"HR:":[281,299],"0.31":[282],"[95%":[283],"CI:":[284],"0.15-0.61];":[285],"mOS":[293],"(15.6":[294],"2.7":[297],"0.25":[300],"[95%CI:":[301],"0.12-0.49];":[302],"0.001).":[305],"deleterious":[307],"effect":[308],"on":[312],"immunotherapy":[313,345],"KRAS":[316,347],"was":[319],"maintained":[320],"when":[321],"controlling":[322],"for":[323],"STK11":[325],"mut.":[326],"Conclusions:":[327],"define":[330],"subset":[333],"unique":[337],"characteristics,":[339],"confer":[341],"worse":[342]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}